Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
Saved in:
| Title: | Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. |
|---|---|
| Authors: | Salazar-Camelo A; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Vega L; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Fadlallah Y; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Bou Rjeily N; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Balshi A; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Morris B; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Ghajarzadeh M; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Mowry EM; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA., Waubant E; Department of Neurology, University of California, San Francisco, CA, USA., Nourbakhsh B; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Oct; Vol. 31 (11), pp. 1338-1347. Date of Electronic Publication: 2025 Sep 19. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585251375350 |
